Scancell Holdings plc announced that Dr Florian Reinaud, aged 50, of Redmile Group, LLC has been appointed as a Non-Executive Director to Scancell's Board of Directors. Florian is a highly accomplished life sciences professional who brings over 20 years of leadership and investment experience across established pharmaceutical companies, start-ups and healthcare investment organisations. He is currently on the investment team at Redmile, an investment firm that focuses on the healthcare sector.

Florian began his career as a medical doctor in the NHS before moving to Schroders Salomon Smith Barney, Citigroup's European investment banking arm, working as an equity analyst covering the pan-European medtech and healthcar e services. He then transitioned to the healthcare team at Apax Partners in Paris, advising on and executing venture and late-stage investments. Following his time at Apax, Partners, Florian became the first CFO of Paris-based DBV technologies, a biopharmaceutical specialising in allergy diagnosis and treatment, and then went on to serve as Partner at CDC Innovation Capital, a French venture capital firm focused on investments in healthcare services, for six years.

He later co-founded and served as CEO of Concilio, a medical concierge service, for six years, before joining Redmile. Florian holds a BA (hons) in Physiology from Oxford University, as well as a medical degree from Imperial College London School of Medicine. Current Directorships: Sensome SAS, Sensorion SA, Hansa Biopharma AB.

Previous Directorships (last 5 years): Concilio.